Prelude Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Prelude Capital Management’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-112,350	Closed	-$1.13M	–	1548
2022 Q4	$1.13M	Buy	112,350 +14,450	+15%	+$143K	0.06%	344
2022 Q3	$961K	Sell	97,900 -58,016	-37%	-$570K	0.03%	443
2022 Q2	$1.52M	Buy	155,916 +2,695	+2%	+$26.4K	0.04%	380
2022 Q1	$1.5M	Hold	153,221	–	–	0.04%	459
2021 Q4	$1.49M	Sell	153,221 -2,750	-2%	-$26.8K	0.04%	432
2021 Q3	$1.51M	Buy	155,971 +2,750	+2%	+$26.7K	0.04%	403
2021 Q2	$1.49M	Buy	+153,221	New	+$1.5M	0.04%	415

Other funds holding AONC

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Prelude Capital Management's AONC Position: Q1 2023 in Review

Prelude Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 112,350 shares — an estimated $1.13M sold.

Prelude Capital Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $1.52M in Q2 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

Prelude Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Prelude Capital Management sold 112,350 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.13M.
Prelude Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
Prelude Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.52M in Q2 2022.
13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.